Concourse Financial Group Securities’s GenMark Diagnostics, Inc GNMK Stock Holding History

Concourse Financial Group Securities’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-275	Closed	-$7K	–	2477
2021 Q1	$7K	Hold	275	–	–	﹤0.01%	1901
2020 Q4	$4K	Buy	+275	New	+$3.65K	﹤0.01%	2005

Concourse Financial Group Securities's GNMK Position: Q2 2021 in Review

Concourse Financial Group Securities sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 275 shares — an estimated $7K sold.

Concourse Financial Group Securities first reported a position in GNMK in Q4 2020 and held it in 2 quarters. The position peaked at $7K in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

Concourse Financial Group Securities reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
Concourse Financial Group Securities sold 275 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $7K.
Concourse Financial Group Securities first reported a position in GenMark Diagnostics, Inc in Q4 2020 and held it in 2 quarters.
Concourse Financial Group Securities's GenMark Diagnostics, Inc position peaked at $7K in Q1 2021.
0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on Concourse Financial Group Securities's 13F filing for Q2 2021, filed 13 Aug 2021.